Dr
Dr Sara Meade
Oncology
About
Dr. Meade specializes in neuro-oncology, particularly in the treatment of skull base and pituitary tumours, as well as in the use of stereotactic radiotherapy. In May 2023, she was appointed Medical Governance Lead at The Harborne Hospital, overseeing the medical governance and ensuring that the hospital maintains the highest standards of care. Her comprehensive expertise also extends to the treatment of brain cancer, gliomas, meningiomas, and other neuro-oncological conditions.
Dr. Meade is committed to advancing oncology through research and clinical trials and is actively involved in teaching the next generation of healthcare professionals.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Sara Meade
Education & training
-
2012–2018 MD · Medicine and Surgery
-
2018–2022 Residency · Oncology
-
2022–2023 Fellowship · Subspecialty training
Career & appointments
-
2022-09–2023-08 Junior consultant
Licenses & insurance
Medical licenses
Board certifications
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 2,188 |
| Annual physical exam | 99395 | 1,042 |
| Vaccination administration | 90471 | 1,866 |
| Minor procedure (skin) | 17110 | 677 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 min | in_clinic | 360.00 EUR |
| Minor procedure (skin) | 120 min | in_clinic | 270.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 5 · i10: 14
-
European registry analysis of Oncology outcomes
DOI: 10.1932/euroclin.2025.0 · PMID: 37534139 · cited by 100
-
Outcomes of Oncology in adults — a multi-centre cohort
DOI: 10.5157/euroclin.2024.1 · PMID: 30465574 · cited by 70
-
European registry analysis of Oncology outcomes
DOI: 10.4254/euroclin.2023.2 · PMID: 37433347 · cited by 144
-
Outcomes of Oncology in adults — a multi-centre cohort
DOI: 10.2017/euroclin.2022.3 · PMID: 35050486 · cited by 58
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
- 🏆 Young Investigator Award · European Society · 2023 · international
Society memberships
- WONCA Europe — Family Doctors — Member · since 2023
- national college of family doctors — Member · since 2023
- European Union of Medical Specialists (UEMS) — Member · since 2023
Patient reviews
- Bedside Manner
- 5.00
- Knowledge
- 5.00
- Wait Time
- 4.72
- Staff Friendliness
- 4.99
- Ease Of Appointment
- 4.87
- Value For Money
- 4.89
- Would Recommend Pct
- 98
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · sara.meade@euroclinics.example
- Accepted intl insurance
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global